The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global PI3 Antibody Market Research Report 2024
Synopsis
PI 3-kinase p85α Antibody (B-9) is an IgG1 κ mouse monoclonal PI 3-kinase p85 alpha antibody (also designated PI3K antibody, p85 alpha antibody, PIK3R1 antibody or phosphoinositide-3-kinase regulatory subunit 1 antibody) that detects the PI 3-kinase p85 alpha protein of mouse, rat and human origin by WB, IP, IF and IHC
Global PI3 Antibody market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole PI3 Antibody market research.
Key manufacturers engaged in the PI3 Antibody industry include Merck, Thermo Fisher Scientific, Proteintech, Cell Signaling Technology, Abcam, ProSci Incorporated, Boster Bio, Bio-Rad and Novus Biologicals, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of PI3 Antibody were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole PI3 Antibody market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global PI3 Antibody market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Merck
Thermo Fisher Scientific
Proteintech
Cell Signaling Technology
Abcam
ProSci Incorporated
Boster Bio
Bio-Rad
Novus Biologicals
Bioss
Abcepta
NSJBio
GeneTex
Aviva Systems Biology
LifeSpan BioSciences
Santa Cruz Biotechnology
Jingjie PTM BioLab
BioDee
Biotend
NeoBioscience Technology
Yeasen Biotechnology
Segment by Type
Monoclonal
Polyclonal
Segment by Application
Immunochemistry (IHC)
Immunofluorescence (IF)
Immunoprecipitation (IP)
Western Blot (WB)
ELISA
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
The PI3 Antibody report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
PI 3-kinase p85α Antibody (B-9) is an IgG1 κ mouse monoclonal PI 3-kinase p85 alpha antibody (also designated PI3K antibody, p85 alpha antibody, PIK3R1 antibody or phosphoinositide-3-kinase regulatory subunit 1 antibody) that detects the PI 3-kinase p85 alpha protein of mouse, rat and human origin by WB, IP, IF and IHC
Global PI3 Antibody market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole PI3 Antibody market research.
Key manufacturers engaged in the PI3 Antibody industry include Merck, Thermo Fisher Scientific, Proteintech, Cell Signaling Technology, Abcam, ProSci Incorporated, Boster Bio, Bio-Rad and Novus Biologicals, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of PI3 Antibody were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole PI3 Antibody market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global PI3 Antibody market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Merck
Thermo Fisher Scientific
Proteintech
Cell Signaling Technology
Abcam
ProSci Incorporated
Boster Bio
Bio-Rad
Novus Biologicals
Bioss
Abcepta
NSJBio
GeneTex
Aviva Systems Biology
LifeSpan BioSciences
Santa Cruz Biotechnology
Jingjie PTM BioLab
BioDee
Biotend
NeoBioscience Technology
Yeasen Biotechnology
Segment by Type
Monoclonal
Polyclonal
Segment by Application
Immunochemistry (IHC)
Immunofluorescence (IF)
Immunoprecipitation (IP)
Western Blot (WB)
ELISA
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
The PI3 Antibody report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index1 PI3 Antibody Market Overview
1.1 Product Overview and Scope of PI3 Antibody
1.2 PI3 Antibody Segment by Type
1.2.1 Global PI3 Antibody Market Value Comparison by Type (2023-2029)
1.2.2 Monoclonal
1.2.3 Polyclonal
1.3 PI3 Antibody Segment by Application
1.3.1 Global PI3 Antibody Market Value by Application: (2023-2029)
1.3.2 Immunochemistry (IHC)
1.3.3 Immunofluorescence (IF)
1.3.4 Immunoprecipitation (IP)
1.3.5 Western Blot (WB)
1.3.6 ELISA
1.3.7 Others
1.4 Global PI3 Antibody Market Size Estimates and Forecasts
1.4.1 Global PI3 Antibody Revenue 2018-2029
1.4.2 Global PI3 Antibody Sales 2018-2029
1.4.3 Global PI3 Antibody Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 PI3 Antibody Market Competition by Manufacturers
2.1 Global PI3 Antibody Sales Market Share by Manufacturers (2018-2023)
2.2 Global PI3 Antibody Revenue Market Share by Manufacturers (2018-2023)
2.3 Global PI3 Antibody Average Price by Manufacturers (2018-2023)
2.4 Global PI3 Antibody Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of PI3 Antibody, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of PI3 Antibody, Product Type & Application
2.7 PI3 Antibody Market Competitive Situation and Trends
2.7.1 PI3 Antibody Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest PI3 Antibody Players Market Share by Revenue
2.7.3 Global PI3 Antibody Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 PI3 Antibody Retrospective Market Scenario by Region
3.1 Global PI3 Antibody Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global PI3 Antibody Global PI3 Antibody Sales by Region: 2018-2029
3.2.1 Global PI3 Antibody Sales by Region: 2018-2023
3.2.2 Global PI3 Antibody Sales by Region: 2024-2029
3.3 Global PI3 Antibody Global PI3 Antibody Revenue by Region: 2018-2029
3.3.1 Global PI3 Antibody Revenue by Region: 2018-2023
3.3.2 Global PI3 Antibody Revenue by Region: 2024-2029
3.4 North America PI3 Antibody Market Facts & Figures by Country
3.4.1 North America PI3 Antibody Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America PI3 Antibody Sales by Country (2018-2029)
3.4.3 North America PI3 Antibody Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe PI3 Antibody Market Facts & Figures by Country
3.5.1 Europe PI3 Antibody Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe PI3 Antibody Sales by Country (2018-2029)
3.5.3 Europe PI3 Antibody Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific PI3 Antibody Market Facts & Figures by Country
3.6.1 Asia Pacific PI3 Antibody Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific PI3 Antibody Sales by Country (2018-2029)
3.6.3 Asia Pacific PI3 Antibody Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America PI3 Antibody Market Facts & Figures by Country
3.7.1 Latin America PI3 Antibody Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America PI3 Antibody Sales by Country (2018-2029)
3.7.3 Latin America PI3 Antibody Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa PI3 Antibody Market Facts & Figures by Country
3.8.1 Middle East and Africa PI3 Antibody Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa PI3 Antibody Sales by Country (2018-2029)
3.8.3 Middle East and Africa PI3 Antibody Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global PI3 Antibody Sales by Type (2018-2029)
4.1.1 Global PI3 Antibody Sales by Type (2018-2023)
4.1.2 Global PI3 Antibody Sales by Type (2024-2029)
4.1.3 Global PI3 Antibody Sales Market Share by Type (2018-2029)
4.2 Global PI3 Antibody Revenue by Type (2018-2029)
4.2.1 Global PI3 Antibody Revenue by Type (2018-2023)
4.2.2 Global PI3 Antibody Revenue by Type (2024-2029)
4.2.3 Global PI3 Antibody Revenue Market Share by Type (2018-2029)
4.3 Global PI3 Antibody Price by Type (2018-2029)
5 Segment by Application
5.1 Global PI3 Antibody Sales by Application (2018-2029)
5.1.1 Global PI3 Antibody Sales by Application (2018-2023)
5.1.2 Global PI3 Antibody Sales by Application (2024-2029)
5.1.3 Global PI3 Antibody Sales Market Share by Application (2018-2029)
5.2 Global PI3 Antibody Revenue by Application (2018-2029)
5.2.1 Global PI3 Antibody Revenue by Application (2018-2023)
5.2.2 Global PI3 Antibody Revenue by Application (2024-2029)
5.2.3 Global PI3 Antibody Revenue Market Share by Application (2018-2029)
5.3 Global PI3 Antibody Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Corporation Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck PI3 Antibody Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Merck PI3 Antibody Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 Thermo Fisher Scientific
6.2.1 Thermo Fisher Scientific Corporation Information
6.2.2 Thermo Fisher Scientific Description and Business Overview
6.2.3 Thermo Fisher Scientific PI3 Antibody Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Thermo Fisher Scientific PI3 Antibody Product Portfolio
6.2.5 Thermo Fisher Scientific Recent Developments/Updates
6.3 Proteintech
6.3.1 Proteintech Corporation Information
6.3.2 Proteintech Description and Business Overview
6.3.3 Proteintech PI3 Antibody Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Proteintech PI3 Antibody Product Portfolio
6.3.5 Proteintech Recent Developments/Updates
6.4 Cell Signaling Technology
6.4.1 Cell Signaling Technology Corporation Information
6.4.2 Cell Signaling Technology Description and Business Overview
6.4.3 Cell Signaling Technology PI3 Antibody Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Cell Signaling Technology PI3 Antibody Product Portfolio
6.4.5 Cell Signaling Technology Recent Developments/Updates
6.5 Abcam
6.5.1 Abcam Corporation Information
6.5.2 Abcam Description and Business Overview
6.5.3 Abcam PI3 Antibody Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Abcam PI3 Antibody Product Portfolio
6.5.5 Abcam Recent Developments/Updates
6.6 ProSci Incorporated
6.6.1 ProSci Incorporated Corporation Information
6.6.2 ProSci Incorporated Description and Business Overview
6.6.3 ProSci Incorporated PI3 Antibody Sales, Revenue and Gross Margin (2018-2023)
6.6.4 ProSci Incorporated PI3 Antibody Product Portfolio
6.6.5 ProSci Incorporated Recent Developments/Updates
6.7 Boster Bio
6.6.1 Boster Bio Corporation Information
6.6.2 Boster Bio Description and Business Overview
6.6.3 Boster Bio PI3 Antibody Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Boster Bio PI3 Antibody Product Portfolio
6.7.5 Boster Bio Recent Developments/Updates
6.8 Bio-Rad
6.8.1 Bio-Rad Corporation Information
6.8.2 Bio-Rad Description and Business Overview
6.8.3 Bio-Rad PI3 Antibody Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Bio-Rad PI3 Antibody Product Portfolio
6.8.5 Bio-Rad Recent Developments/Updates
6.9 Novus Biologicals
6.9.1 Novus Biologicals Corporation Information
6.9.2 Novus Biologicals Description and Business Overview
6.9.3 Novus Biologicals PI3 Antibody Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Novus Biologicals PI3 Antibody Product Portfolio
6.9.5 Novus Biologicals Recent Developments/Updates
6.10 Bioss
6.10.1 Bioss Corporation Information
6.10.2 Bioss Description and Business Overview
6.10.3 Bioss PI3 Antibody Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Bioss PI3 Antibody Product Portfolio
6.10.5 Bioss Recent Developments/Updates
6.11 Abcepta
6.11.1 Abcepta Corporation Information
6.11.2 Abcepta PI3 Antibody Description and Business Overview
6.11.3 Abcepta PI3 Antibody Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Abcepta PI3 Antibody Product Portfolio
6.11.5 Abcepta Recent Developments/Updates
6.12 NSJBio
6.12.1 NSJBio Corporation Information
6.12.2 NSJBio PI3 Antibody Description and Business Overview
6.12.3 NSJBio PI3 Antibody Sales, Revenue and Gross Margin (2018-2023)
6.12.4 NSJBio PI3 Antibody Product Portfolio
6.12.5 NSJBio Recent Developments/Updates
6.13 GeneTex
6.13.1 GeneTex Corporation Information
6.13.2 GeneTex PI3 Antibody Description and Business Overview
6.13.3 GeneTex PI3 Antibody Sales, Revenue and Gross Margin (2018-2023)
6.13.4 GeneTex PI3 Antibody Product Portfolio
6.13.5 GeneTex Recent Developments/Updates
6.14 Aviva Systems Biology
6.14.1 Aviva Systems Biology Corporation Information
6.14.2 Aviva Systems Biology PI3 Antibody Description and Business Overview
6.14.3 Aviva Systems Biology PI3 Antibody Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Aviva Systems Biology PI3 Antibody Product Portfolio
6.14.5 Aviva Systems Biology Recent Developments/Updates
6.15 LifeSpan BioSciences
6.15.1 LifeSpan BioSciences Corporation Information
6.15.2 LifeSpan BioSciences PI3 Antibody Description and Business Overview
6.15.3 LifeSpan BioSciences PI3 Antibody Sales, Revenue and Gross Margin (2018-2023)
6.15.4 LifeSpan BioSciences PI3 Antibody Product Portfolio
6.15.5 LifeSpan BioSciences Recent Developments/Updates
6.16 Santa Cruz Biotechnology
6.16.1 Santa Cruz Biotechnology Corporation Information
6.16.2 Santa Cruz Biotechnology PI3 Antibody Description and Business Overview
6.16.3 Santa Cruz Biotechnology PI3 Antibody Sales, Revenue and Gross Margin (2018-2023)
6.16.4 Santa Cruz Biotechnology PI3 Antibody Product Portfolio
6.16.5 Santa Cruz Biotechnology Recent Developments/Updates
6.17 Jingjie PTM BioLab
6.17.1 Jingjie PTM BioLab Corporation Information
6.17.2 Jingjie PTM BioLab PI3 Antibody Description and Business Overview
6.17.3 Jingjie PTM BioLab PI3 Antibody Sales, Revenue and Gross Margin (2018-2023)
6.17.4 Jingjie PTM BioLab PI3 Antibody Product Portfolio
6.17.5 Jingjie PTM BioLab Recent Developments/Updates
6.18 BioDee
6.18.1 BioDee Corporation Information
6.18.2 BioDee PI3 Antibody Description and Business Overview
6.18.3 BioDee PI3 Antibody Sales, Revenue and Gross Margin (2018-2023)
6.18.4 BioDee PI3 Antibody Product Portfolio
6.18.5 BioDee Recent Developments/Updates
6.19 Biotend
6.19.1 Biotend Corporation Information
6.19.2 Biotend PI3 Antibody Description and Business Overview
6.19.3 Biotend PI3 Antibody Sales, Revenue and Gross Margin (2018-2023)
6.19.4 Biotend PI3 Antibody Product Portfolio
6.19.5 Biotend Recent Developments/Updates
6.20 NeoBioscience Technology
6.20.1 NeoBioscience Technology Corporation Information
6.20.2 NeoBioscience Technology PI3 Antibody Description and Business Overview
6.20.3 NeoBioscience Technology PI3 Antibody Sales, Revenue and Gross Margin (2018-2023)
6.20.4 NeoBioscience Technology PI3 Antibody Product Portfolio
6.20.5 NeoBioscience Technology Recent Developments/Updates
6.21 Yeasen Biotechnology
6.21.1 Yeasen Biotechnology Corporation Information
6.21.2 Yeasen Biotechnology PI3 Antibody Description and Business Overview
6.21.3 Yeasen Biotechnology PI3 Antibody Sales, Revenue and Gross Margin (2018-2023)
6.21.4 Yeasen Biotechnology PI3 Antibody Product Portfolio
6.21.5 Yeasen Biotechnology Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 PI3 Antibody Industry Chain Analysis
7.2 PI3 Antibody Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 PI3 Antibody Production Mode & Process
7.4 PI3 Antibody Sales and Marketing
7.4.1 PI3 Antibody Sales Channels
7.4.2 PI3 Antibody Distributors
7.5 PI3 Antibody Customers
8 PI3 Antibody Market Dynamics
8.1 PI3 Antibody Industry Trends
8.2 PI3 Antibody Market Drivers
8.3 PI3 Antibody Market Challenges
8.4 PI3 Antibody Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
